Hong Kong Just Became Asia's AI Listing Capital, And The Q1 Numbers Are Ridiculous

Hong Kong Just Became Asia's AI Listing Capital, And The Q1 Numbers Are Ridiculous

Hong Kong's IPO market raised nearly $14 billion in the first quarter of 2026, its biggest quarterly haul in five years, and the fuel under the rally is Chinese AI. MiniMax, Zhipu AI trading as Z.ai, and chip designer Biren Technology each priced within weeks of each other, and the after-market performance has been extraordinary. HKEX is no longer a backup for mainland issuers. It is the default Asian venue for pure-play AI equity.

The Q1 Tape

The data tells the story cleanly. Zhipu AI's Hong Kong debut in January priced at the top of its range and finished Q1 up 566% from its IPO price. MiniMax, which lists its own large language model family, ended the quarter up 147%. The two combined raised roughly $1.3 billion. Then on 17 April, Hangzhou-based spatial AI firm Manycore Tech, which operates the Kujiale interior design platform, raised HK$1.22 billion and peaked up 171% on its debut, oversubscribed by more than 300 times.

Behind that list sits a pipeline of more than 400 companies in HKEX's queue, per local filings. Moonshot^✦ AI (the developer of Kimi), smart-glasses firm Rokid, Baidu's chip unit Kunlunxin, and PCB supplier Victory Giant are all reportedly preparing listings. This is not a one-quarter bump. It is a structural rotation of Chinese AI equity away from New York and Shanghai toward Hong Kong.

Why Hong Kong, And Why Now

Three things converged. Mainland listings in Shanghai and Shenzhen have tightened since late 2024, pushing growth-stage issuers offshore. US-listed Chinese ADRs face ongoing delisting risk and frequent volatility halts. And HKEX has actively courted AI issuers with a Chapter 18C framework for specialist technology companies that lowers the revenue and profitability bars. For a Zhipu or a MiniMax, Hong Kong offers capital, liquidity, and far less political uncertainty than Wall Street.

Institutional demand has followed. Global long-only funds that were locked out of onshore A-share access now have a cleaner way to buy Chinese AI exposure. And regional retail flows through the Stock Connect channel mean southbound demand from Shanghai and Shenzhen investors regularly makes up 30 to 40% of first-day volume on these debuts.

If last year focused on big tech, this year there is clear demand to invest in pure AI players such as AI labs and AI hardware corporations.

The Chapter 18C regime has done what it was designed to do. Hong Kong is now the natural home for Chinese AI equity, and that has consequences for every regional capital market.

The Knock-On Effects Across Asia

The listings boom is already rippling outward. Singapore's SGX has publicly acknowledged it is losing mid-cap technology flows to HKEX, and is accelerating its own dual-class share rules. Tokyo Stock Exchange, which had hoped its Growth Market would catch AI IPOs, is now seeing Japanese AI firms assess whether a secondary Hong Kong listing would deepen their float. Korean AI firms that had defaulted to KOSDAQ are exploring HKEX for the first time.

For corporate finance teams elsewhere in Asia, the HKEX rally changes the comparables. If you are pricing an AI business in Jakarta, Bangkok, or Mumbai, the 2026 Hong Kong multiples are now the benchmark^✦ your bankers will use. That pushes valuations up across private secondary markets too.

Beyond The Rally: What Is Actually Trading

Most of the Q1 2026 gains are not rooted in reported revenue. They reflect expectations of token-economy monetisation, enterprise agent deals, and government AI contracts that have yet to show up on P&Ls. Several of these firms are still loss-making. That is the risk: a meaningful pullback in Chinese AI sentiment, or a single regulatory shock from Beijing, could compress the HKEX AI index just as quickly as it expanded.

This is not the first AI capital story we have covered this month. See our analysis of DayOne's $2 billion Singapore data centre round, PayPay's $10 billion Japan IPO, and the broader APAC AI energy build-out. For the semiconductor context, our note on TSMC's 72% foundry share is the best frame for why Biren Technology's raise matters.

Frequently Asked Questions

Why did Chinese AI firms pivot to Hong Kong and not Shanghai or New York?

Mainland listings face tighter Science and Technology Innovation Board reviews, and US-listed Chinese firms face ongoing geopolitical overhang. HKEX's Chapter 18C framework specifically targets pre-revenue specialist tech companies and offers liquidity through Stock Connect.

Are these gains sustainable or bubble-like?

Many of these firms are pre-profitability. Q1 2026 returns reflect forward expectations of token monetisation and enterprise contracts, not reported earnings. A correction of 30 to 50% on any of them would not be surprising and should not shock the underlying thesis.

What happens to Singapore and Tokyo if this continues?

SGX and TSE become second-tier venues for regional AI listings, likely picking up mid-cap Southeast Asian and Japanese issuers while HKEX locks in the Chinese pure-play flow. Expect both exchanges to sharpen their listing rules in the second half of 2026.

Can non-Chinese investors access these IPOs easily?

Yes. Global institutional investors can participate in HKEX IPOs directly or via international book-running syndicates. Retail exposure is available through Hong Kong brokerages and, for many regions, via international retail platforms that offer HK-listed shares.

How much of your 2026 AI equity allocation is now priced off HKEX comparables? Drop your take in the comments below.